MDG2 fundamentals
An in-depth look to MEDIGENE AG operating, investing, and financing activities
MDG2 free cash flow for H1 24 is -7.09 M EUR. For 2023, MDG2 free cash flow was -15.78 M EUR and operating cash flow was -15.12 M EUR.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM